Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-4
SponsorCairo University

About this trial

Intussusception is one of the most frequent causes of acute bowel and second most common cause of acute abdominal pain in pediatric age .95 % of cases are idiopathic, the rest are either due to pathological lead point or post operative. Treatment of intussusception must start with medical resuscitation, then radiological or operative reduction of intussusception.

Our surgery team has used hydrocortisone with the medical resuscitation to improve the success rate of pneumatic reduction and decrease the number of reduction trials.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Infantile Intussusception

Disqualifiers

Peritonitis Pneumoperitoneum Morbid patients

Trial design

Design model

Parallel

Treatments tested in this trial

  • Hydrocortisone

    Drug

    10 mg/kg with Resuscitation before attempting pneumatic reduction, single dose with Resuscitation before attempting reduction

  • Saline

    Drug

    100 ml with Resuscitation before attempting pneumatic reduction, single dose with Resuscitation before attempting reduction

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: HydrocortisoneExperimental treatment 1 intervention
Group B: SalinePlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Success of Pneumatic Reduction

Comparing number of Successful Pneumatic Reductions in both groups

Time frame
1 Hour

Secondary outcomes

1

Reducing number of trials of Pneumatic Reduction

Comparing average number of Pneumatic Reduction trials between both groups

Time frame
2 Hours
2

Reducing complications

Comparing number of complications in both groups

Time frame
2 Hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.